BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Staging
6 results:

  • 1. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (pd-l1) in patients with cervical cancer.
    Liu KH; Yang W; Tian HP
    Clin Radiol; 2024 Feb; 79(2):e264-e272. PubMed ID: 37926648
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical cancer: an open-label, single-arm, phase II trial.
    Chen J; Li C; Cao Y; Zhu L; Zhang B; You J; Hou H; Wang J; Yuan Z
    BMC Cancer; 2022 Jul; 22(1):793. PubMed ID: 35854236
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
    Okonogi N; Usui H; Murata K; Hori M; Kurokawa T; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Hasegawa S; Yamada S; Hanaoka H; Shozu M; Tsuji H
    BMJ Open; 2022 Mar; 12(3):e056424. PubMed ID: 35236732
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Focused Neck Ultrasound and Lymph Node Sampling by Respiratory Physicians in Suspected Lung cancer.
    Hassan M; Nicholson T; Taylor L; McDill H; Hadden R; Syred K; Riordan R; Howell T; Corcoran JP; Daneshvar C
    Respiration; 2022; 101(1):57-62. PubMed ID: 34515221
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunoscore system combining CD8 and PD-1/pd-l1: A novel approach that predicts the clinical outcomes for cervical cancer.
    Chen H; Xia B; Zheng T; Lou G
    Int J Biol Markers; 2020 Mar; 35(1):65-73. PubMed ID: 31808707
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immune Checkpoint Blockade in pd-l1-Positive Platinum-Refractory cervical Carcinoma.
    Tewari KS
    J Clin Oncol; 2019 Jun; 37(17):1449-1454. PubMed ID: 31026210
    [No Abstract]    [Full Text] [Related]  


    of 1.